IPC: These 5 countries recognize Indian Pharmacopoeia (IP)

Last Updated on October 10, 2024 by The Health Master

Recognition of Indian Pharmacopoeia:

The Indian Pharmacopoeia Commission (IPC) has achieved significant milestones in expanding the recognition and acceptance of the Indian Pharmacopoeia (IP) in foreign countries.

Recent Memoranda of Understanding (MoUs) have been signed with various nations, including:

• Suriname,
• Afghanistan,
• Ghana,
• Nepal,
• Mauritius.

These agreements signify the growing global recognition of IP as a reputable pharmacopoeia, highlighting its role in ensuring the quality of drugs and health products.

Suriname:

IP Recognized through MoU with the Health Ministry In a recent development, the IPC signed an MoU with the Health Ministry of Suriname (Republic of Suriname) to formally recognize the Indian Pharmacopoeia.

The IPC had submitted proposals to Suriname’s health ministry, as well as other key ministries, including health and family welfare, commerce and industry, and external affairs, to enhance efforts towards global recognition and acceptance of IP.

Afghanistan:

IP Becomes the First Recognized Pharmacopoeia The National Department of Regulation of Medicines and Health Products, under Afghanistan’s Ministry of Public Health, officially recognized the Indian Pharmacopoeia.

IP will serve as a reputable pharmacopoeia, providing essential standards for the quality assessment of medicines and health products in laboratories. Afghanistan holds the distinction of being the first country to recognize IP.

Ghana:

IP as an Approved Reference in Public Health Act Within the framework of the Fourth Schedule of the Public Health Act, Ghana acknowledges IP as an approved reference.

When the monographs in IP are compared with those in recognized pharmacopoeias, IP is considered a reliable source in Ghana’s pharmaceutical sector.

Nepal:

IP as a Book of Standards in Drugs Category Rules The Drugs Category Rules 1986 in Nepal categorizes the Indian Pharmacopoeia as a book of standards.

Under Schedule 1 of the Drugs Category Rules 1986, IP, published by the Ministry of Health, Government of India, occupies the third position in the list of pharmacopoeias or encyclopedias related to drug categories.

Mauritius:

IP Included in Pharmaceutical Standards Mauritius has taken steps to include IP in the standards for pharmaceuticals.

An amendment was made to Section 2 of the Pharmacy Act 1983 through the legal supplement published in August 2020.

The definition of “specified standards” in Section 2 of the Pharmacy Act now explicitly mentions “European or Indian,” removing the previous reference to only “European” standards.

Continued Improvements and Updates in IP:

To ensure the quality of drugs in India, the Union Health Ministry released the 9th edition of IP in July of the previous year (2022).

This edition introduced 92 new monographs for drugs, 12 new general chapters, 1,245 monographs for formulations, and 930 monographs for active pharmaceutical ingredients (APIs).

Additionally, dissolution specifications for all prolonged release formulations were provided. With these additions, the current edition of IP encompasses a total of 3,152 monographs.

The IPC also revised numerous monographs and general chapters to align with current global requirements and harmonize with other renowned pharmacopoeias such as the USP and the BP.

Conclusion:

The recognition and acceptance of the Indian Pharmacopoeia (IP) in various countries, including Suriname, Afghanistan, Ghana, Nepal, and Mauritius, mark significant milestones for IPC’s efforts to enhance global standards in the pharmaceutical industry.

These developments reinforce IP’s position as a trusted source for ensuring the quality, safety, and efficacy of drugs and health products.

For informative videos by The Health Master, click on the below YouTube icon:

• Fire explosion at Aurore Pharmaceuticals
  November 21, 2024
• Drug recall: Cipla recalls over 1.8k boxes of this drug
  November 21, 2024
• USFDA issued Form 483 with 7 observations to Dr Reddy’s
  November 20, 2024
• NPPA Revises Ceiling Prices of these Key Drugs
  November 20, 2024
• Approval of Anti Cancer drug Nivolumab for new Indication
  November 19, 2024
• Trump 2.0 Agenda: A Boon for Indian Pharma Industry?
  November 19, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: